the absence of J&J in any comms after or leading up to these results is probably the most baffling part.
that may by in large explain the lacklustre share price action after the results were released.
if they try go it alone with the FDA, it could be a long and expensive route.
J&J Partnership, page-364
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.010(2.74%) |
Mkt cap ! $78.59M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.5¢ | $19.78K | 54.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 125990 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 4170 | 1 |
View Market Depth
| Last trade - 15.33pm 22/08/2024 (20 minute delay) ? |
| OCC (ASX) Chart |